William Larry Gluck

Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

William Larry Gluck, Deborah Hurst, Alan R. Yuen et al. · Clinical Cancer Research · 2004 · 165 citations · Full text

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma

William Larry Gluck, Mrinal M. Gounder, Richard C. Frank et al. · Investigational New Drugs · 2019 · 120 citations · Full text

Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.

Dana V. Devine, William Larry Gluck, Wendell F. Rosse et al. · Journal of Clinical Investigation · 1987 · 58 citations · Full text

Hematological Malignancy, Laboratory Hematology, Autoimmune Disease +13

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19

William Larry Gluck, Sean Callahan, Robert Brevetta et al. · Respiratory Medicine · 2020 · 40 citations · Full text

Acute Lymphoblastic Leukemia of Burkitt’s Type (L3 ALL) with 8;22 and 14; 18 Translocations and Absent Surface Immunoglobulins

William Larry Gluck, Sandra H. Bigner, Michael J. Borowitz et al. · American Journal of Clinical Pathology · 1986 · 37 citations